FDA Delays Nonprescription Drug Rules to May 27
Published Date: 3/25/2025
Rule
Summary
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
Analyzed Economic Effects
6 provisions identified: 2 benefits, 4 costs, 0 mixed.
FDA May Refuse Applications That Don't Meet Requirements
The rule specifies that FDA will refuse to approve an application for a nonprescription drug product with an ACNU if the application fails to meet the applicable requirements.
Separate NDA/ANDA Required for ACNU Switches
If you want to market a nonprescription drug that includes an additional condition for nonprescription use (ACNU) and a prescription version is already approved, you must submit a new drug application (NDA) or abbreviated new drug application (ANDA) for the nonprescription product instead of submitting a supplement to the existing prescription approval.
Effective Date Delayed to May 27, 2025
The rule that would change how some nonprescription drugs are regulated was supposed to take effect on January 27, 2025, was previously delayed to March 21, 2025, and is now delayed again to May 27, 2025. This gives affected parties an additional 60 days to review and prepare for the new requirements.
New Labeling Content and Format Rules
The final rule sets specific requirements for the content and format of labeling statements for nonprescription drug products with an ACNU. Manufacturers must follow those labeling content and format rules when marketing such products.
Exemption From 'Adequate Directions' Labeling Requirement
The rule exempts a nonprescription drug product with an ACNU from the requirement to be labeled with adequate directions for use if certain labeling conditions are met and the ACNU is implemented as approved by FDA.
Required Postmarketing Reports for ACNU Failures
Applicants must submit a postmarketing report if an ACNU fails. The rule establishes a postmarketing reporting requirement specifically for ACNU failures.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
2026-20721, Requirements for Additional Traceability Records for Certain Foods: Enforcement Policy for Certain Retail Food Establishments and Restaurants; Draft Guidance for Industry; Availability
The FDA is sharing a draft plan about new food tracking rules that mostly won’t apply to certain stores and restaurants right now. If you run a retail food place or restaurant, you don’t have to worry about extra paperwork just yet, but the FDA wants your feedback by November 23, 2026. This helps them decide the final rules without causing extra costs or hassle for small businesses.
Previous / Next Documents
Previous: 2025-04971, Unaccompanied Children Program Foundational Rule; Update To Accord With Statutory Requirements
This new rule updates how the government cares for unaccompanied children in federal custody by fixing a rule that didn’t match the law. It affects kids in the program and the people helping them, allowing better info-sharing with law enforcement when needed. The rule kicks in on March 25, 2025, and folks can share their thoughts until May 27, 2025.
Next: 2025-05041, Fisheries of the Exclusive Economic Zone Off Alaska; Reallocation of Pacific Cod in the Bering Sea and Aleutian Islands Management Area
Starting March 20, 2025, NMFS is shifting 1,000 metric tons of Pacific cod from jig-gear boats to smaller catcher vessels using hook-and-line or pot gear in the Bering Sea and Aleutian Islands. This change helps make sure the 2025 Pacific cod catch limit is fully used and supports fishermen with different gear types. The reallocation lasts through the end of 2025 and aims to keep the fishing season fair and productive.